Médicaments génériques

Cnam 2027 Report: Deprescription as a Strategic Lever for Healthcare Savings

by

The French National Health Insurance fund, known as the Caisse nationale de l’Assurance maladie (Cnam), has officially identified “deprescribing” as a central strategy in its 2027 “Charges and Products” report to optimize pharmaceutical expenditure and improve patient safety. This initiative seeks to empower pharmacists to actively participate in the review and potential discontinuation of unnecessary … Read more

Understanding the Effects and Risks of Pharmaceutical Excipients

by

When we pick up a prescription at the pharmacy, our attention is almost exclusively focused on the active pharmaceutical ingredient—the chemical compound designed to treat our ailment. However, tablets, capsules and syrups are complex chemical matrices. Beyond the medicine itself, they contain a variety of substances known as excipients. While these are generally classified as … Read more